Want to retire wealthy? I’d buy these 2 FTSE 100 dividend shares for a rising passive income

These two FTSE 100 (INDEXFTSE:UKX) stocks have the pedigree to deliver long-term dividend income growth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Who doesn’t want to retire wealthy? Spending your later years free of financial worries, and making the most of all that free time, is a universal dream.

I think the best way to achieve it is to invest in a portfolio of stocks and shares, using your tax-free Stocks and Shares ISA. I’d suggest looking at these two top FTSE 100 dividend and growth stocks.

AstraZeneca

The AstraZeneca (LSE: AZN) share price has been flying lately, up 25% over the last year, and 75% over five years. This is a tribute to CEO Pascal Soriot, who has worked hard to turn the company around since joining in 2012. Investors were concerned that the pharmaceutical giant’s pipeline of new drugs was running dry, at the same time as several blockbuster treatments came off patent, allowing generic competitors to pile in to its patch.

Soriot responded by pouring money into R&D and it is starting to pay off, as the group gets regulatory approval for a number of new medicines.

AstraZeneca has raised its sales guidance twice in the last year, with full-year product sales up 12% to a hefty $23.6bn, while sales of new medicines rose 59% to $9.9bn. While the coronavirus could hit Chinese earnings, recent strong performance gives it a cushion.

Another concern is that the US Presidential election could whip up public anger over drugs pricing. However, in the longer run, our ageing society will need all the pharmaceuticals it can get, and AstraZeneca is in a good place right now. The stock currently yields just 2.8%, but that partly reflects strong recent share price growth, and you can expect dividends to rise steadily over time. AstraZeneca stock isn’t cheap, trading at 24.2 times forward earnings, but that’s because it is a quality stock.

BAE Systems

The BAE Systems (LSE: BA) share price has climbed an impressive 43% over the past 12 months, re-establishing its reputation as one of the top FTSE 100 stocks around.

Its recent full-year results also impressed, with sales up 7% to £20.1bn, and operating business cash flow up more than 30% to £1.3bn. Crucially for income investors, dividends totalled 23.2p per share for the year, up 4.5% compared to last year. This kind of growth is vital, because it means payouts are growing faster than inflation, which gives you a rising passive income from your portfolio.

One concern is its large pension deficit, but it is taking advantage of low interest rates to fund £1bn of accelerated pension deficit funding.

Despite the surge in BAE Systems stock, the shares still only trade at 13.8 times earnings, which makes now look like an attractive entry point to me. The forecast yield of 3.6% is covered twice by earnings, and as we have seen, looks set to rise much faster than inflation.

Top FTSE 100 dividend growth stocks like these two are exactly what you need to generate the rising passive income that can help you get the most out of life during your retirement.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

One English pound placed on a graph to represent an economic down turn
Investing Articles

FTSE 100 shares yield under 4%. Here’s why that matters!

A higher dividend yield and share price growth do not necessarily come together. So, why is this writer happy to…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

Here’s how I’d start buying shares with £5 a day

Our writer uses his market experience to consider how he might start buying shares from scratch today, for just a…

Read more »

Investing Articles

By investing £80 a week, I can target a £3k+ second income like this

By putting £80 each week into carefully chosen shares, our writer hopes to build a second income of over £3,000…

Read more »

Dividend Shares

Here’s a simple 4-stock dividend income portfolio with a 7.8% yield

With these four British dividend stocks, an investor could potentially generate income of around £780 a year from a £10,000…

Read more »

A young black man makes the symbol of a peace sign with two fingers
Investing Articles

2 FTSE shares that could get hit by Trump tariffs

Many FTSE shares rely on the US for business and the potential introduction of tariffs on foreign imports could hurt…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Finding shares to buy can be complicated. Here’s a lesson from the US election

Identifying shares to buy is difficult. But Stephen Wright thinks monitoring what directors buy might be an under-appreciated source of…

Read more »

Investing Articles

What makes a great passive income idea?

Christopher Ruane earns passive income by owning blue-chip shares like Legal & General. Here's the decision-making process that helps him…

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

Here’s how I’d try and use an ISA to become a multi-millionaire!

Could our writer build his ISA to a multi-million pound valuation? Potentially yes -- and here is how he'd go…

Read more »